Zimvie In Share Price (NASDAQ: ZIMV)

$18.98

▲

0.01

(0.05%)

Live

Last updated on August 28, 2025 at 12:44 am IST

$₹

Check the interactive Zimvie In Stock chart to analyse performance

Zimvie In stock performance

as on August 28, 2025 at 12:44 am IST

Today's Low:$18.96
Today's High:$18.99
$18.98
0.11%
Downside
Day's Volatility :0.16%
Upside
0.05%
52 Weeks Low:$8.15
52 Weeks High:$19.01
$18.98
57.06%
Downside
52 Weeks Volatility :57.12%
Upside
0.13%

Zimvie In Stock Returns

Period	Zimvie In	Sector (Health Care)	Index (Russel 2000)
3 Months	115.57%	3.7%	0.0%
6 Months	44.81%	-6.9%	0.0%
1 Year	9.15%	-11.9%	0.0%
3 Years	17.39%	7.7%	-6.9%

Zimvie In Key Stats

Check Zimvie In key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$18.97
Open	$18.96
Today's High	$18.99
Today's Low	$18.96
Market Capitalization	$534.7M
Today's Volume	$298.8K
52 Week High	$19.005
52 Week Low	$8.15
Revenue TTM	$443.4M
EBITDA	$41.0M
Earnings Per Share (EPS)	$-0.69
Profit Margin	-4.39%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4.76%

Stock Returns calculator for Zimvie In Stock including INR - Dollar returns

The Zimvie In stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zimvie In investment value today

Current value as on today

₹1,13,879

Returns

₹13,879

(+13.88%)

Returns from Zimvie In Stock

₹9,206 (+9.21%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Zimvie In Stock

-43%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Zimvie In Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Zimvie In

Name
Holdings %
Name
Holdings %
Eversept Partners, LLC
7.37%
BlackRock Inc
6.98%
Camber Capital Management LLC
6.68%
Vanguard Group Inc
6.36%
J. Goldman & Co LP
5.13%
Dimensional Fund Advisors, Inc.
4.84%

Analyst Recommendation on Zimvie In Stock

Rating

Trend

Sell

0%Buy

42%Hold

57%Sell

Based on 7 Wall street analysts offering stock ratings for Zimvie In(by analysts ranked 0 to 5 stars)

Zimvie In Share Price Target

What analysts predicted

Upside of 0.11%

Target:

$19.00

Current:

$18.98

Zimvie In share price target is $19.00, a slight Upside of 0.11% compared to current price of $18.98 as per analysts' prediction.

Zimvie In Stock Insights

Price Movement
In the last 3 months, ZIMV stock has moved up by 116.1%
Increasing Revenue
Revenue is up for the last 4 quarters, 103.22M → 116.66M (in $), with an average increase of 4.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.47M → -3.94M (in $), with an average decrease of 168.3% per quarter
ZIMV vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 33.3% return, outperforming this stock by 24.2%
ZIMV vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 162.6% return, outperforming this stock by 144.6%
Price to Sales
ForZIMV every $1 of sales, investors are willing to pay $1.2, whereas for Boston Scientific Corp., the investors are paying $8.5 for every $1 of sales.

Zimvie In Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.1B	↓ 3.97%
Net Income	$-27.9M	↓ 93.94%
Net Profit Margin	-2.64%	↑ 39.25%

	FY20	Y/Y Change
Revenue	$912.4M	↓ 13.56%
Net Income	$-179.0M	↑ 541.58%
Net Profit Margin	-19.62%	↓ 16.98%

	FY21	Y/Y Change
Revenue	$1.0B	↑ 11.2%
Net Income	$-95.3M	↓ 46.76%
Net Profit Margin	-9.39%	↑ 10.23%

	FY22	Y/Y Change
Revenue	$913.9M	↓ 9.93%
Net Income	$-63.9M	↓ 32.97%
Net Profit Margin	-6.99%	↑ 2.4%

	FY23	Y/Y Change
Revenue	$457.4M	↓ 49.95%
Net Income	$-393.3M	↑ 515.65%
Net Profit Margin	-85.98%	↓ 78.99%

	FY24	Y/Y Change
Revenue	$449.7M	↓ 1.68%
Net Income	$-25.8M	↓ 93.43%
Net Profit Margin	-5.74%	↑ 80.24%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$118.2M	↑ 4.54%
Net Income	$-7.8M	↓ 97.68%
Net Profit Margin	-6.57%	↑ 289.59%

	Q2 FY24	Q/Q Change
Revenue	$116.8M	↓ 1.17%
Net Income	$-4.0M	↓ 48.28%
Net Profit Margin	-3.44%	↑ 3.13%

	Q3 FY24	Q/Q Change
Revenue	$103.2M	↓ 11.63%
Net Income	$-2.3M	↓ 43.1%
Net Profit Margin	-2.21%	↑ 1.23%

	Q4 FY24	Q/Q Change
Revenue	$111.5M	↑ 8.04%
Net Income	$-11.8M	↑ 415.15%
Net Profit Margin	-10.55%	↓ 8.34%

	Q1 FY25	Q/Q Change
Revenue	$112.0M	↑ 0.43%
Net Income	$-1.5M	↓ 87.5%
Net Profit Margin	-1.31%	↑ 9.24%

	Q2 FY25	Q/Q Change
Revenue	$116.7M	↑ 4.17%
Net Income	$-3.9M	↑ 168.32%
Net Profit Margin	-3.38%	↓ 2.07%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$721.6M	↑ 0.73%

	FY20	Y/Y Change
Profit	$599.5M	↓ 16.92%

	FY21	Y/Y Change
Profit	$628.8M	↑ 4.89%

	FY22	Y/Y Change
Profit	$613.1M	↓ 2.5%

	FY23	Y/Y Change
Profit	$290.4M	↓ 52.64%

	FY24	Y/Y Change
Profit	$287.4M	↓ 1.01%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$73.9M	↑ 14.88%

	Q2 FY24	Q/Q Change
Profit	$73.3M	↓ 0.87%

	Q3 FY24	Q/Q Change
Profit	$67.4M	↓ 8.04%

	Q4 FY24	Q/Q Change
Profit	$72.8M	↑ 8.03%

	Q1 FY25	Q/Q Change
Profit	$74.0M	↑ 1.69%

	Q2 FY25	Q/Q Change
Profit	$75.3M	↑ 1.7%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$119.2M	↓ 26.42%
Investing Cash Flow	$-84.6M	↑ 68.19%
Financing Cash Flow	$-43.7M	↓ 55.09%

	FY20	Y/Y Change
Operating Cash Flow	$86.0M	↓ 27.85%
Investing Cash Flow	$-49.5M	↓ 41.49%
Financing Cash Flow	$-46.5M	↑ 6.41%

	FY21	Y/Y Change
Operating Cash Flow	$64.3M	↓ 25.23%
Investing Cash Flow	$-60.3M	↑ 21.82%
Financing Cash Flow	$72.3M	↓ 255.48%

	FY22	Y/Y Change
Operating Cash Flow	$24.6M	↓ 61.7%
Investing Cash Flow	$-28.7M	↓ 52.47%
Financing Cash Flow	$-1.3M	↓ 101.81%

	FY23	Y/Y Change
Operating Cash Flow	$37.1M	↑ 50.84%
Investing Cash Flow	$-15.2M	↓ 47.06%
Financing Cash Flow	$-25.7M	↑ 1863.73%

	FY24	Y/Y Change
Operating Cash Flow	$14.2M	↓ 61.84%
Investing Cash Flow	$282.3M	↓ 1960.39%
Financing Cash Flow	$-294.7M	↑ 1048.08%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-11.5M	↓ 153.65%
Investing Cash Flow	$-4.1M	↑ 51.52%
Financing Cash Flow	$-1.4M	↓ 83.82%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$3.0M	↓ 126.37%
Investing Cash Flow	$289.8M	↓ 7104.28%
Financing Cash Flow	$-275.2M	↑ 19053.31%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$1.2M	↓ 60.51%
Investing Cash Flow	$-530.0K	↓ 100.18%
Financing Cash Flow	$-18.8M	↓ 93.18%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$21.5M	↑ 1688.99%
Investing Cash Flow	$-2.9M	↑ 442.08%
Financing Cash Flow	$776.0K	↓ 104.13%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-13.9M	↓ 164.85%
Investing Cash Flow	$-1.9M	↓ 32.23%
Financing Cash Flow	$-1.1M	↓ 246.26%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$3.2M	↓ 123.21%
Investing Cash Flow	$-7.4M	↑ 281.61%
Financing Cash Flow	$426.0K	↓ 137.53%

Zimvie In Technicals Summary

Sell

Neutral

Buy

Zimvie In is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Zimvie In Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zimvie In	0.8%	44.81%	9.15%	17.39%	-25.7%
Medtronic Plc	0.22%	1.76%	3.8%	3.67%	-14.54%
Edwards Lifesciences Corp.	3.54%	12.94%	16.72%	-10.06%	-3.63%
Boston Scientific Corp.	0.54%	4.78%	33.3%	163.46%	159.35%
Stryker Corporation	-1.53%	0.72%	10.05%	90.79%	99.06%
Abbott Laboratories	4.16%	-3.2%	16.37%	29.23%	18.79%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zimvie In	NA	NA	NA	0.91	-0.05	0.01	NA	14.64
Medtronic Plc	25.61	25.61	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	34.0	34.0	4.83	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.57	62.57	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.64	51.64	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.55	16.55	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zimvie In	Sell	$534.7M	-25.7%	NA	-4.39%
Medtronic Plc	Buy	$118.8B	-14.54%	25.61	13.63%
Edwards Lifesciences Corp.	Buy	$47.7B	-3.63%	34.0	72.96%
Boston Scientific Corp.	Buy	$155.7B	159.35%	62.57	13.55%
Stryker Corporation	Buy	$149.4B	99.06%	51.64	12.25%
Abbott Laboratories	Buy	$229.5B	18.79%	16.55	32.43%

About Zimvie In

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.

Organization	Zimvie In
Employees	1770
CEO	Mr. Vafa Jamali
Industry	Healthcare

Key Management of Zimvie In

Name	Title
Mr. Vafa Jamali	President, CEO & Chairman of the Board
Mr. Richard J. Heppenstall	Executive VP, CFO & Treasurer
Ms. Heather Kidwell	Senior VP, Chief Legal, HR & Compliance Officer and Corporate Secretary
Mr. Indraneel Kanaglekar	Senior VP & Chief Commercial Officer
Sandra Schneider	Chief Accounting Officer
Mr. Steve Rondeau	Senior VP & Chief Information Officer

Important FAQs about investing in ZIMV Stock from India :

What is Zimvie In share price today?

Zimvie In share price today is $18.98 as on August 28, 2025 at 12:44 am IST. Zimvie In share today touched a day high of $18.99 and a low of $18.96.

What is the 52 week high and 52 week low for Zimvie In share?

Zimvie In share touched a 52 week high of $19.01 and a 52 week low of $8.15. Zimvie In stock price today i.e. August 28, 2025 at 12:44 am IST is trending at $18.98, lower by 0.13% versus the 52 week high.

How to invest in Zimvie In Stock (ZIMV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zimvie In on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zimvie In Shares that will get you 0.0790 shares as per Zimvie In share price of $18.98 per share as on August 28, 2025 at 12:44 am IST.

What is the minimum amount required to buy Zimvie In Stock (ZIMV) from India?

Indian investors can start investing in Zimvie In (ZIMV) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Zimvie In stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Zimvie In share’s latest price of $18.98 as on August 28, 2025 at 12:44 am IST, you will get 0.5269 shares of Zimvie In. Learn more about fractional shares .

What are the returns that Zimvie In has given to Indian investors in the last 5 years?

Zimvie In stock has given -25.7% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?